{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:52:45Z","timestamp":1773294765725,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.biopsych.2005.03.019","type":"journal-article","created":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T11:08:52Z","timestamp":1114945732000},"page":"589-594","source":"Crossref","is-referenced-by-count":136,"title":["Open-Label, 8-Week Trial of Olanzapine and Risperidone for the Treatment of Bipolar Disorder in Preschool-Age Children"],"prefix":"10.1016","volume":"58","author":[{"given":"Joseph","family":"Biederman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Mick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Hammerness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Harpold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Aleardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2005.03.019_bib1","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1176\/appi.ajp.159.8.1337","article-title":"Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence","volume":"159","author":"Aman","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.019_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004583-200001000-00016","article-title":"Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS)","volume":"39","author":"Ambrosini","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.019_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cap.2005.15.311","article-title":"An Open-label trial of risperidone in children and adolescents with bipolar disorder","volume":"15","author":"Biederman","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.biopsych.2005.03.019_bib4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archpsyc.1997.01830230069010","article-title":"A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression","volume":"54","author":"Emslie","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.019_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/10445460152595568","article-title":"A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder","volume":"11","author":"Frazier","year":"2001","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.biopsych.2005.03.019_bib6","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/00004583-200211000-00017","article-title":"Discriminative validity of a parent version of the Young Mania Rating Scale","volume":"41","author":"Gracious","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.019_bib7","series-title":"Four Factor Index of Social Status","author":"Hollingshead","year":"1975"},{"key":"10.1016\/j.biopsych.2005.03.019_bib8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1037\/1040-3590.13.3.384","article-title":"New subscales for an anchored version of the brief psychiatric rating scale","volume":"13","author":"Lachar","year":"2001","journal-title":"Psychol Assess"},{"key":"10.1016\/j.biopsych.2005.03.019_bib9","first-page":"839","article-title":"CGI (Clinical Global Impression) Scale\u2014NIMH","volume":"21","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.biopsych.2005.03.019_bib10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania","volume":"156","author":"Tohen","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.019_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00004583-200203000-00005","article-title":"Psychiatric comorbidity and functioning in clinically referred preschoolers and school aged youth with ADHD","volume":"41","author":"Wilens","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.019_bib12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00004583-199507000-00010","article-title":"Mania-like symptoms suggestive of childhood onset bipolar disorder in clinically referred children","volume":"34","author":"Wozniak","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.019_bib13","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/01.jcp.0000084036.22282.ea","article-title":"Efficacy of atypical antipsychotics in mood disorders","volume":"23","author":"Yatham","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2005.03.019_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.019_bib15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1207\/S15374424JCCP3104_15","article-title":"Factor structure of the Young Mania Rating Scale for use with youths ages 5 to 17 years","volume":"31","author":"Youngstrom","year":"2002","journal-title":"J Clin Child Adolesc Psychol"},{"key":"10.1016\/j.biopsych.2005.03.019_bib16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.283.8.1025","article-title":"Trends in the prescribing of psychotropic medications to preschoolers","volume":"283","author":"Zito","year":"2000","journal-title":"JAMA"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322305003598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322305003598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T04:05:46Z","timestamp":1683086746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322305003598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0006322305003598"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2005.03.019","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}